Qingxin Mu

10PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Chitosan-PEG Nanoparticles for Co-Delivery of Paclitaxel and KRAS G12D-Directed siRNA to Pancreatic Cancer Cells.

|Jul 28, 2026
Combination Therapeutic Delivery Systems.

|Oct 26, 2024
An Efficient Fabrication Approach for Multi-Cancer Responsive Chemoimmuno Co-Delivery Nanoparticles.

Jianxi Huang, Yu-Ting Chien, Qingxin Mu

|Aug 29, 2024
Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression.

Jesse Yu, Xiaolin Xu, James Ian Griffin

|Mar 28, 2024
Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.

James I Griffin, Xinyue Chen, Luqi Duan

|Mar 29, 2023
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure.

James Griffin, Yan Wu, Qingxin Mu

Pageof 2

Frequent Collaborators

4 joint publications

Miqin Zhang

2 joint publications

Rodney J Y Ho

2 joint publications

Jesse Yu

2 joint publications

James Ian Griffin